Streamlining Transitions Between Academic and Community Centers

January 28, 2025

Jeffrey V. Matous, MD

Opinion

Video

Jeffrey V. Matous, MD, discusses how telehealth and remote monitoring can enhance the safe administration of bispecific antibody therapies in community settings, especially for rural or underserved populations, while emphasizing the importance of communication and collaboration between academic and community practices to improve delivery and coordination of care.

EP: 1.Emerging Bispecifics in Multiple Myeloma: Real-World Insights and Treatment Strategies

EP: 2.Navigating Adverse Events in Bispecific Antibody Therapies: Infection Prevention and Management

EP: 3.Proactive CRS Management: The Role of Tocilizumab and Beyond

EP: 4.Expanding Bispecific Therapies to Community Settings: Challenges and Innovations

EP: 5.Leveraging Telehealth and Collaboration for Rural and Community Care Expansion

Now Viewing

EP: 6.Streamlining Transitions Between Academic and Community Centers

EP: 7.Optimizing Care Models for Bispecific Antibodies: Strategies for Cost-Effective Delivery

Video content above is prompted by the following:

How can telehealth and remote monitoring, including tools for managing CRS or other toxicities, support the safe administration of bispecific antibody therapies in community settings while expanding access for rural or underserved populations?
How can academic and community practices strengthen communication and collaboration to support the delivery of bispecific antibody therapies, and what tools or frameworks might facilitate this coordination?